Role of HMGB1 in cardiovascular diseases

被引：108

作者：

Li, W

Sama, AE

Wang, HC

机构：

[1] NYU, Sch Med, N Shore Univ Hosp, Dept Emergency Med, Manhasset, NY 11030 USA

[2] Feinstein Inst Med Res, Ctr Immunol & Inflammat, Manhasset, NY 11030 USA

来源：

CURRENT OPINION IN PHARMACOLOGY | 2006年 / 6卷 / 02期

关键词：

D O I：

10.1016/j.coph.2005.10.010

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

A nuclear protein, high mobility group box 1 (HMGB1), is released passively by necrotic cells, and actively by macrophages/monocytes in response to exogenous and endogenous inflammatory stimuli. After binding to the receptor for advanced glycation end products (RAGE) or toll-like receptor 4 (TLR4), HMGB1 activates vascular endothelial cells and macrophages/monocytes to express proinflammatory cytokines, chemokines and adhesion molecules. Pharmacological suppression of its activities or release is protective against lethal endotoxemia and sepsis, establishing HMGB1 as a critical mediator of lethal systemic inflammation. In light of the pathogenic role of inflammation in cardiovascular diseases, we propose that HMGB1, a proinflammatory cytokine derived from both injured endothelium and activated macrophages/monocytes, could contribute to the progression of atherosclerosis and other cardiovascular diseases.

引用

收藏

页码：130 / 135

页数：6

相关论文

共 58 条

[41] Release of chromatin protein HMGB1 by necrotic cells triggers inflammation [J].

Scaffidi, P ;

Misteli, T ;

Bianchi, ME .

NATURE, 2002, 418 (6894) :191-195

[42] Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock [J].

Sundén-Cullberg, J ;

Norrby-Teglund, A ;

Rouhiainen, A ;

Rauvala, H ;

Herman, G ;

Tracey, KJ ;

Lee, ML ;

Andersson, J ;

Tokics, L ;

Treutiger, CJ .

CRITICAL CARE MEDICINE, 2005, 33 (03) :564-573

[43] High mobility group 1 B-box mediates activation of human endothelium [J].

Treutiger, CJ ;

Mullins, GE ;

Johansson, ASM ;

Rouhiainen, A ;

Rauvala, HME ;

Erlandsson-Harris, H ;

Andersson, U ;

Yang, H ;

Tracey, KJ ;

Andersson, J ;

Palmblad, JEW .

JOURNAL OF INTERNAL MEDICINE, 2003, 254 (04) :375-385

[44] The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion [J].

Tsung, A ;

Sahai, R ;

Tanaka, H ;

Nakao, A ;

Fink, MP ;

Lotze, MT ;

Yang, H ;

Li, JH ;

Tracey, KJ ;

Geller, DA ;

Billiar, TR .

JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (07) :1135-1143

[45] Contributions of high mobility group box protein in experimental and clinical acute lung injury [J].

Ueno, H ;

Matsuda, T ;

Hashimoto, S ;

Amaya, F ;

Kitamura, Y ;

Tanaka, M ;

Kobayash, A ;

Maruyama, I ;

Yamada, S ;

Hasegawa, N ;

Soejima, J ;

Koh, H ;

Ishizaka, A .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (12) :1310-1316

[46] Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation [J].

Ulloa, L ;

Ochani, M ;

Yang, H ;

Tanovic, M ;

Halperin, D ;

Yang, R ;

Czura, CJ ;

Fink, MP ;

Tracey, KJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) :12351-12356

[47] Extracellular role of HMGB1 in inflammation and sepsis [J].

Wang, H ;

Yang, H ;

Tracey, KJ .

JOURNAL OF INTERNAL MEDICINE, 2004, 255 (03) :320-331

[48] Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis [J].

Wang, H ;

Liao, H ;

Ochani, M ;

Justiniani, M ;

Lin, XC ;

Yang, LH ;

Al-Abed, Y ;

Wang, HC ;

Metz, C ;

Miller, EJ ;

Tracey, KJ ;

Ulloa, L .

NATURE MEDICINE, 2004, 10 (11) :1216-1221

[49] The aqueous extract of a popular herbal nutrient supplement, Angelica sinensis, protects mice against lethal endotoxemia and sepsis [J].

Wang, HC ;

Li, W ;

Li, JH ;

Rendon-Mitchell, B ;

Ochani, M ;

Ashok, M ;

Yang, LH ;

Yang, H ;

Tracey, KJ ;

Wang, P ;

Sama, AE .

JOURNAL OF NUTRITION, 2006, 136 (02) :360-365

[50] Lipid unites disparate syndromes of sepsis [J].

Wang, HC ;

Czura, CJ ;

Tracey, KJ .

NATURE MEDICINE, 2004, 10 (02) :124-125

← 1 2 3 4 5 6 →